Literature DB >> 27747010

Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.

Youngkyu Moon1, Sook Whan Sung1, Kyo Young Lee2, Jae Kil Park1.   

Abstract

BACKGROUND: Ground glass opacity (GGO) generally associated with the lepidic component of lung adenocarcinoma. However, in some cases, GGO nodules have been associated with invasive adenocarcinomas, where a lepidic component is minimal or absent. The purpose of this study is to evaluate the clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as GGO nodules.
METHODS: We reviewed computed tomography (CT) images from 168 patients diagnosed with non-lepidic invasive adenocarcinoma classified as stage T1N0M0 (≤3 cm) who underwent curative anatomical resection. Tumors were classified according to radiologic features: 31 were GGO predominant (Group A) and 137 were solid predominant (Group B). The clinicopathological findings and recurrence free survival were used as outcome measures.
RESULTS: The mean percentages of micropapillary and solid component in tumor was higher in Group B than Group A (P<0.001) Pleural invasion and lymphatic invasion were more frequently seen in Group B. The presence of tumors with a micropapillary component was higher in Group B (P=0.040). The 3-year recurrence-free survival was lower in Group B than Group A (80.4% vs. 100%, P=0.019). Risk factors for recurrence such as presence of a micropapillary component and lymphatic invasion were more frequently seen in Group B.
CONCLUSIONS: Non-lepidic invasive adenocarcinoma presenting as GGO has fewer risk factors and better prognosis when compared with those presenting as solid tumors. Therefore, the presence of GGO on chest CT is a good prognostic indicator for lung cancer irrespective of histomorphologic classification.

Entities:  

Keywords:  Lung cancer; ground glass opacity (GGO); invasive adenocarcinoma; prognosis

Year:  2016        PMID: 27747010      PMCID: PMC5059258          DOI: 10.21037/jtd.2016.08.46

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

Review 2.  What is the most practical, optimal, and cost effective method for performing follow-up after lung cancer surgery, and by whom should it be done?

Authors:  Lise Tremblay; Jean Deslauriers
Journal:  Thorac Surg Clin       Date:  2013-06-28       Impact factor: 1.750

3.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

4.  Fifty years of cancer incidence: CI5 I-IX.

Authors:  D Max Parkin; Jacques Ferlay; Maria-Paula Curado; Freddie Bray; Brenda Edwards; Hai-Rim Shin; David Forman
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

5.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

6.  Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.

Authors:  Shinsuke Sasada; Haruhiko Nakayama; Yoshihiro Miyata; Norifumi Tsubokawa; Takahiro Mimae; Tomoharu Yoshiya; Shuji Murakami; Hiroyuki Ito; Morihito Okada
Journal:  Ann Thorac Surg       Date:  2015-01-23       Impact factor: 4.330

7.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

8.  Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: a review of 5 years' experience.

Authors:  Chi-Wei Duann; Jung-Jyh Hung; Po-Kuei Hsu; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Yu-Chung Wu; Wen-Hu Hsu
Journal:  J Chin Med Assoc       Date:  2013-10-04       Impact factor: 2.743

9.  Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.

Authors:  Ha Young Kim; Young Mog Shim; Kyung Soo Lee; Joungho Han; Chin A Yi; Yoon Kyung Kim
Journal:  Radiology       Date:  2007-10       Impact factor: 11.105

10.  Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.

Authors:  Youngkyu Moon; Kyung Soo Kim; Sook Whan Sung; Kyo-Young Lee; Young Kyoon Kim; Jin Hyoung Kang; Yeon Sil Kim; Jae Kil Park
Journal:  World J Surg Oncol       Date:  2014-12-17       Impact factor: 2.754

View more
  14 in total

1.  Bilateral uniportal video-assisted thoracic surgery segmentectomy S3: an unusual case.

Authors:  Alonso José Oviedo Argueta; Sonia Raquelline Roque Cañas; Yuming Zhu; Diego Gonzalez-Rivas
Journal:  J Vis Surg       Date:  2017-11-11

2.  Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection.

Authors:  Youngkyu Moon; Kyo Young Lee; Jae Kil Park
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

3.  Clinical characteristics and prognosis of ground-glass opacity nodules in young patients.

Authors:  Jun Wang; Han Ma; Chong-Jun Ni; Jing-Kang He; Hai-Tao Ma; Jin-Feng Ge
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Selecting therapy for small ground-glass tumors-the potential role of volumetric computed tomography scan.

Authors:  Xiangwen Wu; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

5.  Predictive factors for invasive adenocarcinoma in patients with clinical non-invasive or minimally invasive lung cancer.

Authors:  Youngkyu Moon; Jae Kil Park; Kyo Young Lee; Seha Ahn; Jinwon Shin
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

6.  Establishment and verification of a prediction model based on clinical characteristics and positron emission tomography/computed tomography (PET/CT) parameters for distinguishing malignant from benign ground-glass nodules.

Authors:  Rong Niu; Xiaonan Shao; Xiaoliang Shao; Zhenxing Jiang; Jianfeng Wang; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 7.  New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies.

Authors:  Donglai Chen; Chenyang Dai; Xiermaimaiti Kadeer; Rui Mao; Yongbing Chen; Chang Chen
Journal:  Ther Clin Risk Manag       Date:  2018-01-31       Impact factor: 2.423

Review 8.  Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.

Authors:  Wei Wang; Zaoxiu Hu; Jie Zhao; Yunchao Huang; Sunyin Rao; Jichen Yang; Shouyong Xiao; Run Cao; Lianhua Ye
Journal:  J Cardiothorac Surg       Date:  2020-06-29       Impact factor: 1.637

9.  Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers.

Authors:  Pai-Hsi Chen; Kuo-Ming Chang; Wei-Chi Tseng; Chien-Hung Chen; Jui-I Chao
Journal:  Thorac Cancer       Date:  2019-09-30       Impact factor: 3.500

10.  Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response.

Authors:  Zhe Wang; Minghuan Li; Yong Huang; Li Ma; Hui Zhu; Li Kong; Jinming Yu
Journal:  Onco Targets Ther       Date:  2018-05-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.